2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Stargardt Disease: new trials by email Literature Review of Stargardt Disease trials Research Report on Stargardt Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt Disease Tinlarebant, Placebo - Stargardt Disease 1 | Phase 3 | Completed | Belite Bio, Inc | 104 | 2022-03-28 | 2026-07-23 |
| Safety and Efficacy of Emixustat in Stargardt Disease Emixustat, Placebo - Stargardt Disease | Phase 3 | Completed | Kubota Vision Inc. | 194 | 2019-01-07 | 2024-05-30 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Macular Degeneration (2) · Retinal Degeneration (2) · Retinal Diseases (2)
emixustat (1)
Belite Bio, Inc (1) · Kubota Vision Inc. (1)
France (2) · Germany (2) · Netherlands (2) · United Kingdom (2) · United States (2) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · China (1) · Denmark (1) · Hong Kong (1) · Italy (1) · South Africa (1) · Spain (1)
Jeff Gregory, MD (1)